BMY: Bristol-Myers Squibb Company Stocks News on April 23, 2025

BMY

MT Newswires

11 hours ago

Citigroup Adjusts Bristol-Myers Squibb Price Target to $51 From $55

Bristol Myers Stock Falls After Drug Trial Setback. Why 1 Analyst Isn’t Worried.

BMY

Barrons.com

12 hours ago

Bristol Myers Stock Falls After Drug Trial Setback. Why 1 Analyst Isn’t Worried.

Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect

BMY

StockStory

12 hours ago

Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect

These Stocks Are Moving the Most Today: Tesla, Intel, Bristol Myers, SAP, Boeing, AT&T, and More

BMY

Barrons.com

12 hours ago

These Stocks Are Moving the Most Today: Tesla, Intel, Bristol Myers, SAP, Boeing, AT&T, and More

BMY

MT Newswires

12 hours ago

Deutsche Bank Adjusts Bristol-Myers Squibb Price Target to $51 From $53, Maintains Hold Rating

BMY

Clinical Trials Arena

14 hours ago

BMS’ schizophrenia therapy fails in Phase III trial as an adjunctive treatment

Bristol Myers’ prized schizophrenia drug stumbles in testing

BMY

BioPharma Dive

15 hours ago

Bristol Myers’ prized schizophrenia drug stumbles in testing

Bristol Myers Sheds 6% After Promising Schizophrenia Drug Flops In Phase 3 Test

BMY

Investor's Business Daily

a day ago

Bristol Myers Sheds 6% After Promising Schizophrenia Drug Flops In Phase 3 Test

Patent Cliff Looms Large for Bristol-Myers Squibb Stock (BMY)

BMY

TipRanks

a day ago

Patent Cliff Looms Large for Bristol-Myers Squibb Stock (BMY)

BMY

MT Newswires

2 days ago

Piper Sandler Initiates Bristol-Myers Squibb at Overweight With $65 Price Target

BMY

MT Newswires

3 days ago

Bristol-Myers Says US FDA Updates Prescribing Information for Cardiac Myosin Inhibitor Camzyos

Bristol Myers says FDA updates Camzyos label to simplify treatment

BMY

TipRanks

5 days ago

Bristol Myers says FDA updates Camzyos label to simplify treatment

Bristol-Myers Squibb (NYSE:BMY) Gains FDA Approval To Simplify Camzyos Monitoring Process

BMY

Simply Wall St.

5 days ago

Bristol-Myers Squibb (NYSE:BMY) Gains FDA Approval To Simplify Camzyos Monitoring Process

Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics

BMY

Zacks

5 days ago

Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics

U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications

BMY

Business Wire

6 days ago

U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications

Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?

BMY

Zacks

6 days ago

Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?

BMY

MT Newswires

6 days ago

BMO Capital Adjusts Bristol-Myers Squibb Price Target to $53 From $61

Bristol Myers Squibb (BMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

BMY

Zacks

6 days ago

Bristol Myers Squibb (BMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Bristol Myers Squibb (BMY) Stock Moves -1.35%: What You Should Know

BMY

Zacks

7 days ago

Bristol Myers Squibb (BMY) Stock Moves -1.35%: What You Should Know

Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?

BMY

Insider Monkey

7 days ago

Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?

BMY

Morningstar Research

7 days ago

Analyst Report: Bristol-Myers Squibb Company

Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News

BMY

Zacks

7 days ago

Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News

Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?

BMY

Zacks

7 days ago

Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?

BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial

BMY

Clinical Trials Arena

8 days ago

BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy for Long Term Growth?

BMY

Insider Monkey

8 days ago

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy for Long Term Growth?

BMY

MT Newswires

8 days ago

Bristol-Myers Squibb, Optellum Collaborate to Boost Early Lung Cancer Diagnosis

BMY

MT Newswires

8 days ago

Sector Update: Health Care Stocks Lower to Flat Premarket Tuesday

BMY Down on Heart Drug Camzyos Failure in Late-Stage Study

BMY

Zacks

8 days ago

BMY Down on Heart Drug Camzyos Failure in Late-Stage Study

Bristol-Myers Squibb Company (BMY): Among the Best Value Dividend Stocks to Buy According to Billionaires?

BMY

Insider Monkey

9 days ago

Bristol-Myers Squibb Company (BMY): Among the Best Value Dividend Stocks to Buy According to Billionaires?

BMY

Argus Research

9 days ago

Analyst Report: Bristol-Myers Squibb Co.

BMY

Argus Research

9 days ago

Market Digest: BK, BMY, BLK, CAVA

Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It

BMY

Investor's Business Daily

9 days ago

Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It

BMY

MT Newswires

9 days ago

Bristol-Myers' Camzyos Phase 3 Trial Misses Dual Primary Endpoints

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

BMY

Business Wire

9 days ago

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

BMS’ Opdivo combo approved in US for hepatocellular carcinoma

BMY

Pharmaceutical Technology

10 days ago

BMS’ Opdivo combo approved in US for hepatocellular carcinoma

BMY

MT Newswires

12 days ago

Bristol-Myers Squibb Gets FDA Approval for Opdivo-Yervoy Combo in Liver Cancer Treatment

Biotech Stock Bounces From Support, Shows Relative Strength Amid Volatile Market

BMY

Investor's Business Daily

12 days ago

Biotech Stock Bounces From Support, Shows Relative Strength Amid Volatile Market

Is Bristol-Myers Squibb Company (BMY) One of the Best Medical Stocks to Buy According to Billionaires?

BMY

Insider Monkey

12 days ago

Is Bristol-Myers Squibb Company (BMY) One of the Best Medical Stocks to Buy According to Billionaires?

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

BMY

Business Wire

12 days ago

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

BMY

MT Newswires

12 days ago

Bristol-Myers Squibb Investors Likely to Focus on Performance of New Schizophrenia Therapy, UBS Says

BMY

MT Newswires

12 days ago

Citigroup Adjusts Price Target on Bristol-Myers Squibb to $55 From $65, Keeps Neutral Rating

BMY

StockStory

12 days ago

3 Value Stocks in the Doghouse

BMY

MT Newswires

12 days ago

UBS Cuts Price Target on Bristol-Myers Squibb to $54 From $60, Keeps Neutral Rating

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

BMY

Investor's Business Daily

13 days ago

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

BMY

Zacks

14 days ago

The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb

Here's Why Bristol Myers Squibb (BMY) Gained But Lagged the Market Today

BMY

Zacks

14 days ago

Here's Why Bristol Myers Squibb (BMY) Gained But Lagged the Market Today

BMY

MT Newswires

14 days ago

Sector Update: Health Care Stocks Gain Late Afternoon

Bristol-Myers Squibb Company (BMY): Among the High Growth Dividend Paying Stocks to Invest in

BMY

Insider Monkey

14 days ago

Bristol-Myers Squibb Company (BMY): Among the High Growth Dividend Paying Stocks to Invest in

BMY

MT Newswires

14 days ago

Bristol-Myers Squibb Reportedly Gets Dismissal of Pomalyst Monopoly Suit

Bristol-Myers Squibb (NYSE:BMY) Achieves Early FDA Approval for Opdivo Plus Yervoy Therapy

BMY

Simply Wall St.

14 days ago

Bristol-Myers Squibb (NYSE:BMY) Achieves Early FDA Approval for Opdivo Plus Yervoy Therapy

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

BMY

Zacks

14 days ago

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

BMY Gets FDA Nod for Label Expansion of Opdivo plus Yervoy Combo

BMY

Zacks

14 days ago

BMY Gets FDA Nod for Label Expansion of Opdivo plus Yervoy Combo

BMY

Investing.com

15 days ago

Goldman turns cautious on major pharma names, sees select upside at Eli Lilly

BMY

Morningstar Research

19 days ago

Analyst Report: Bristol-Myers Squibb Company

BMY

Zacks

20 days ago

The Zacks Analyst Blog Highlights Exxon Mobil, Bristol-Myers Squibb, Chubb and Hamilton Beach Brands

Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street

BMY

The Wall Street Journal

20 days ago

Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street

Top Research Reports for Exxon Mobil, Bristol-Myers Squibb & Chubb

BMY

Zacks

21 days ago

Top Research Reports for Exxon Mobil, Bristol-Myers Squibb & Chubb

Is Bristol Myers Squibb's High-Yielding Dividend Safe?

BMY

Motley Fool

22 days ago

Is Bristol Myers Squibb's High-Yielding Dividend Safe?

CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo

BMY

Zacks

22 days ago

CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

BMY

Zacks

22 days ago

Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

Is Bristol-Myers Squibb (BMY) One of the Best Healthcare Stocks to Buy According to Billionaires?

BMY

Insider Monkey

22 days ago

Is Bristol-Myers Squibb (BMY) One of the Best Healthcare Stocks to Buy According to Billionaires?

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

BMY

Zacks

22 days ago

Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

Beat the S&P 500 With This Cash-Gushing Dividend Stock

BMY

Motley Fool

22 days ago

Beat the S&P 500 With This Cash-Gushing Dividend Stock

Bristol-Myers Squibb Company (BMY): Among the Best High Yield Stocks to Buy in April for Dividend Capture

BMY

Insider Monkey

23 days ago

Bristol-Myers Squibb Company (BMY): Among the Best High Yield Stocks to Buy in April for Dividend Capture

Jim Cramer on Bristol-Myers Squibb. Co (NYSE:BMY): They Should Have Known Better

BMY

Insider Monkey

25 days ago

Jim Cramer on Bristol-Myers Squibb. Co (NYSE:BMY): They Should Have Known Better

Why Bristol-Myers Squibb Co. (BMY) Went Up On Friday?

BMY

Insider Monkey

a month ago

Why Bristol-Myers Squibb Co. (BMY) Went Up On Friday?

Bristol-Myers Squibb (NYSE:BMY) Sees Rising Interest in Sotyktu Despite 3% Share Price Dip

BMY

Simply Wall St.

a month ago

Bristol-Myers Squibb (NYSE:BMY) Sees Rising Interest in Sotyktu Despite 3% Share Price Dip

BMY

MT Newswires

a month ago

Bristol-Myers Squibb Says New Opdivo Formulation Recommended for Approval by EU Regulatory Panel

Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...

BMY

Business Wire

a month ago

Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

BMY

Business Wire

a month ago

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form

BMY

Yahoo Finance

a month ago

Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form

Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates

BMY

Zacks

a month ago

Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates

3 Deeply Discounted Dividend Stocks to Buy Today

BMY

Motley Fool

a month ago

3 Deeply Discounted Dividend Stocks to Buy Today

Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts

BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts

Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”

BMY

Insider Monkey

a month ago

Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”

1 Large-Cap Stock on Our Watchlist and 2 to Brush Off

BMY

StockStory

a month ago

1 Large-Cap Stock on Our Watchlist and 2 to Brush Off

Is Bristol-Myers Squibb (BMY) The Best Healthcare Dividend Stock to Invest in?

BMY

Insider Monkey

a month ago

Is Bristol-Myers Squibb (BMY) The Best Healthcare Dividend Stock to Invest in?

8 key drug patents expiring soon — and what it means for the market

BMY

Quartz

a month ago

8 key drug patents expiring soon — and what it means for the market

Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires?

BMY

Insider Monkey

a month ago

Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires?

Bristol-Myers Squibb Company (BMY): Among Incredibly Cheap Dividend Stock to Buy Now

BMY

Insider Monkey

a month ago

Bristol-Myers Squibb Company (BMY): Among Incredibly Cheap Dividend Stock to Buy Now

Is Bristol-Myers Squibb Company (BMY) The Best Undervalued Stock to Buy According to Billionaires?

BMY

Insider Monkey

a month ago

Is Bristol-Myers Squibb Company (BMY) The Best Undervalued Stock to Buy According to Billionaires?

2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

BMY

Motley Fool

a month ago

2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note

BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note

Is Bristol-Myers Squibb (BMY) the Most Undervalued Biotech Stock to Invest In?

BMY

Insider Monkey

a month ago

Is Bristol-Myers Squibb (BMY) the Most Undervalued Biotech Stock to Invest In?

Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination

BMY

TipRanks

a month ago

Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination

Bristol-Myers Squibb Company (BMY): A Bull Case Theory

BMY

Insider Monkey

a month ago

Bristol-Myers Squibb Company (BMY): A Bull Case Theory

EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy

BMY

Pharmaceutical Technology

a month ago

EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy

Why Bristol-Myers Squibb Company (BMY) Went Down On Friday?

BMY

Insider Monkey

a month ago

Why Bristol-Myers Squibb Company (BMY) Went Down On Friday?

Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment

BMY

Simply Wall St.

a month ago

Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment

BMY

MT Newswires

a month ago

Bristol-Myers Squibb Says EU Approves Breyanzi for Relapsed, Refractory Follicular Lymphoma

$Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma$

BMY

Business Wire

a month ago

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.

BMY

The Wall Street Journal

a month ago

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.

BMY

Zacks

a month ago

Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts

Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?

BMY

Zacks

a month ago

Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?

Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025

BMY

Business Wire

a month ago

Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds?

BMY

Insider Monkey

a month ago

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds?

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

BMY

Zacks

a month ago

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

BMS to acquire longtime cell therapy partner 2seventy bio for $286m

BMY

Pharmaceutical Technology

a month ago

BMS to acquire longtime cell therapy partner 2seventy bio for $286m

TSVT Up on Acquisition Agreement With BMY for $286 Million

BMY

Zacks

a month ago

TSVT Up on Acquisition Agreement With BMY for $286 Million

BMY

MT Newswires

a month ago

Latest Bristol-Myers Squibb Company (BMY) News on April 23, 2025

Share on Social Networks: